Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr ...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...

Low total cholesterol levels were tied to an increased risk of death for pulmonary fibrosis patients with disease of unknown ...

fibrosis, inflammation, and overall reduced cardiac function. How these changes impact the right heart remains unknown. Our group uses two models of right heart failure- high altitude induced ...

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

Pulmonary fibrosis, or idiopathic pulmonary fibrosis ... it can cause respiratory failure and subsequently right heart failure. The only treatment available at this stage is a lung transplant ...